RAB39B as a Chemosensitivity-Related Biomarker for Diffuse Large B-Cell Lymphoma
Background: Diffuse large B-cell lymphoma (DLBCL) is the most common aggressive lymphoma with an increased tendency to relapse or refractoriness. RAB39B, a member of the Ras-oncogene superfamily, is associated with a variety of tumors. Nevertheless, the role of RAB39B in DLBCL is still unknown. This...
Saved in:
Main Authors: | Cong Xu (Author), Ting Liang (Author), Jing Liu (Author), Yunfeng Fu (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Serum Cystatin C as a Biomarker in Diffuse Large B-Cell Lymphoma
by: Nada E. Hammouda, et al.
Published: (2017) -
The current status and future trends of BTK inhibitor for diffuse large B cell lymphoma
by: Qiuni Chen, et al.
Published: (2024) -
Subcutaneous nodules in a patient with diffuse large B‐cell lymphoma
by: Benjamin Liang Jun Lui, et al.
Published: (2024) -
Primary diffuse large B-cell lymphoma of the mandible
by: Juliana Mota Siqueira, et al.
Published: (2019) -
Identification of prognostic factors in patients with diffuse large B-cell lymphoma
by: Fang Peng, et al.
Published: (2017)